VIA Pharmaceuticals Insider Trades

VIAP

Track insider trading activity from VIA Pharmaceuticals executives and directors. See which insiders are buying and selling VIAP stock.

Trades Last 12 Months

All Insider Trades for VIA Pharmaceuticals

Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Craves Fred B Director
Holding Value $2.6k 5,205,325 shares
Last Trade
Nov 15, 2010 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.00
Wright Karen Steil V.p. ? Finance, Controller
Holding Value $31.9 63,826 shares
Last Trade
Apr 01, 2010 Sale
No data
No data
$0.00
Cohen Lawrence Kenneth CEO And President
Holding Value $210 419,660 shares
Last Trade
Dec 17, 2008 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Holding Value $5 10,000 shares
Last Trade
Dec 17, 2008 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Bagnall Mark Director
Holding Value $5 10,000 shares
Last Trade
Dec 17, 2008 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Taub Rebecca Svp, Research & Development
Holding Value $78.8 157,500 shares
Last Trade
Dec 17, 2008 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Olukotun Adeoye Y Chief Medical Officer
Holding Value $60 120,000 shares
Last Trade
Dec 17, 2007 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Flynn James E 10% owner, other, Possible Member Of 10% Group
Holding Value $622 1,244,708 shares
Last Trade
Nov 06, 2007 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up